facebook
Home > Investor Relations > Newsroom > News

Email This Print ThisNews

Change - Announcement Of Appointment Of Independent Non-Executive Director

BackApr 03, 2025
Announcement Title Change - Announcement of Appointment
Date & Time of Broadcast Apr 3, 2025 17:57
Status New
Announcement Sub Title Appointment of Independent Non-Executive Director
Announcement Reference SG250403OTHRLKLC
Submitted By (Co./ Ind. Name) Yap Kok Cheng
Designation Executive Chairman & CEO
Description (Please provide a detailed description of the event in the box below) Appointment of Independent Non-Executive Director - Mr Yap Beng Tat, Richard
Additional Details
Date Of Appointment 07/04/2025
Name Of Person Yap Beng Tat, Richard
Age 43
Country Of Principal Residence Singapore
The Board's comments on this appointment (including rationale, selection criteria, board diversity considerations, and the search and nomination process) As part of the board renewal process, the Nominating Committee ("NC") has reviewed the board structure, as well as the background of Mr Yap Beng Tat, Richard ("Mr Yap") and is of the view that Mr Yap's experience and credentials will bring valuable expertise and provide different perspectives to the Board. The appointment of Mr Yap as Independent Non-Executive Director of the Company based on NC's recommendation has been approved by the Board.
Whether appointment is executive, and if so, the area of responsibility The appointment is independent and non-executive.
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) Independent Non-Executive Director
Chairman of Remuneration Committee
Member of Nominating Committee
Member of Audit & Risk Management Committee
Professional qualifications - Chartered Financial Analyst (CFA) - Member
- Chartered Accountant Singapore (CA Singapore) - Member
- Chartered Valuer and Appraiser (CVA) - Member
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries No
Conflict of interests (including any competing business) No
Working experience and occupation(s) during the past 10 years July 2022 - Present:
CEO and Founder, NAVI Corporate Advisory Pte Ltd

April 2017 - July 2022:
Senior Director - Head of Business Valuation, SEA, Cushman & Wakefield Group

October 2011 - April 2017:
Director - Valuation and Advisory, Censere Group
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6)) Yes
Shareholding interest in the listed issuer and its subsidiaries? No
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years) Singapore Paincare Holdings Limited
Present (1) Navi Corporate Advisory Pte. Ltd.
(2) Navi Corporate Advisory Sdn Bhd
(3) Navi Corporate Advisory (HK) Limited
(4) IP Egg Singapore Pte. Ltd. (non-executive)
(5) Aero Plus (Singapore) Pte. Ltd. (non-executive)
(6) Sky Honour Education Pte. Ltd. (non-executive)
(7) Winery Plus Pte. Ltd. (non-executive)
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner? No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency? No
(c) Whether there is any unsatisfied judgment against him? No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose? No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach? No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part? No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust? No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust? No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity? No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust? No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere? No
Any prior experience as a director of an issuer listed on the Exchange? Yes
If Yes, Please provide details of prior experience June 2020 - February 2024:
Independent Director, Singapore Paincare Holdings Limited